Glynib 400mg (Imatinib Mesylate 400mg)

Description

Glynib 400mg is a targeted therapy medicine containing Imatinib Mesylate, specifically designed to act directly on cancer cells. It works by blocking abnormal proteins that promote the growth of cancer cells, helping to either eliminate them or control their spread in the body.

This medication is highly effective in the treatment of Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST), where it plays a vital role in managing disease progression and improving patient outcomes.